G. Thomas Passananti

1.4k total citations
39 papers, 1.1k citations indexed

About

G. Thomas Passananti is a scholar working on Pharmacology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, G. Thomas Passananti has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 10 papers in Molecular Biology and 9 papers in Clinical Biochemistry. Recurrent topics in G. Thomas Passananti's work include Pharmacogenetics and Drug Metabolism (11 papers), Metabolism and Genetic Disorders (9 papers) and Pharmacology and Obesity Treatment (4 papers). G. Thomas Passananti is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Metabolism and Genetic Disorders (9 papers) and Pharmacology and Obesity Treatment (4 papers). G. Thomas Passananti collaborates with scholars based in United States and Switzerland. G. Thomas Passananti's co-authors include Elliot S. Vesell, John G. Page, Frank E. Greene, Carol A. Shively, Barry Dvorchik, E.S. Vesell, Jay R. Shapiro, William J. White, C. Max Lang and A. Wallace Hayes and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

G. Thomas Passananti

39 papers receiving 939 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Thomas Passananti United States 19 401 206 185 172 147 39 1.1k
L.J. Fischer United States 18 324 0.8× 261 1.3× 159 0.9× 206 1.2× 130 0.9× 52 1.3k
Frank E. Greene United States 20 389 1.0× 210 1.0× 86 0.5× 71 0.4× 126 0.9× 45 1.0k
Carol B. Pantuck United States 20 382 1.0× 217 1.1× 99 0.5× 180 1.0× 114 0.8× 41 1.2k
DS Davies United Kingdom 18 827 2.1× 266 1.3× 172 0.9× 169 1.0× 384 2.6× 33 1.4k
N. Rietbrock Germany 19 218 0.5× 361 1.8× 109 0.6× 147 0.9× 147 1.0× 147 1.4k
W Kalow Canada 17 668 1.7× 263 1.3× 177 1.0× 168 1.0× 306 2.1× 35 1.1k
Eugene J. Pantuck United States 29 830 2.1× 390 1.9× 244 1.3× 337 2.0× 255 1.7× 52 2.0k
GC Kahn United Kingdom 15 529 1.3× 178 0.9× 120 0.6× 126 0.7× 248 1.7× 20 892
W Klinger Germany 18 400 1.0× 257 1.2× 63 0.3× 159 0.9× 218 1.5× 158 1.2k
D. Kadar Canada 15 293 0.7× 130 0.6× 148 0.8× 125 0.7× 129 0.9× 29 729

Countries citing papers authored by G. Thomas Passananti

Since Specialization
Citations

This map shows the geographic impact of G. Thomas Passananti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Thomas Passananti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Thomas Passananti more than expected).

Fields of papers citing papers by G. Thomas Passananti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Thomas Passananti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Thomas Passananti. The network helps show where G. Thomas Passananti may publish in the future.

Co-authorship network of co-authors of G. Thomas Passananti

This figure shows the co-authorship network connecting the top 25 collaborators of G. Thomas Passananti. A scholar is included among the top collaborators of G. Thomas Passananti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Thomas Passananti. G. Thomas Passananti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vesell, Elliot S., et al.. (1994). Pyrazinoylguanidine Downregulates the Glucose Fatty‐Acid Cycle in Hypertensive, Hyperinsulinemic Diabetic Patients. The Journal of Clinical Pharmacology. 34(12). 1234–1245. 3 indexed citations
2.
Vesell, Elliot S., Charles E. Chambers, G. Thomas Passananti, Laurence M. Demers, & Karl H. Beyer. (1993). Effects of Pyrazinoylguanidine on the Glucose‐Fatty Acid Cycle in Normal Subjects and Patients with Non‐Insulin‐Dependent Diabetes Mellitus. The Journal of Clinical Pharmacology. 33(9). 823–831. 5 indexed citations
3.
Vesell, Elliot S., et al.. (1992). Pyrazinoylguanidine: antihypertensive, hypocholesterolemic, and renin effects.. PubMed. 32(12). 1128–34. 9 indexed citations
4.
Chambers, Charles E., et al.. (1992). Pyrazinoylguanidine: Antihypertensive, Hypocholesterolemic, and Renin Effects. The Journal of Clinical Pharmacology. 32(12). 1128–1134. 7 indexed citations
5.
Passananti, G. Thomas, et al.. (1990). Reproducibility of individual rates of ethanol metabolism in fasting subjects. Clinical Pharmacology & Therapeutics. 47(3). 389–396. 12 indexed citations
6.
Doolittle, David J., Edward S. Riccio, G. Thomas Passananti, et al.. (1990). Comparative studies of the mutagenicity of urine from smokers and non-smokers on a controlled non-mutagenic diet. Food and Chemical Toxicology. 28(9). 639–646. 13 indexed citations
7.
Vickers, Florence F., et al.. (1989). On the antipyrine test in laboratory animals. Studies in the dog and monkey.. Drug Metabolism and Disposition. 17(2). 160–165. 17 indexed citations
8.
Doolittle, David J., Gary T. Burger, Bruce Reed, et al.. (1989). Effect of cooking methods on the mutagenicity of food and on urinary mutagenicity of human consumers. Food and Chemical Toxicology. 27(10). 657–666. 42 indexed citations
9.
Shively, Carol A., Stanley M. Tarka, Maurice J. Arnaud, et al.. (1985). High levels of methylxanthines in chocolate do not alter theobromine disposition. Clinical Pharmacology & Therapeutics. 37(4). 415–424. 29 indexed citations
10.
Penno, Margaret B., et al.. (1984). Sources of interindividual variations in acetaminophen and antipyrine metabolism. Clinical Pharmacology & Therapeutics. 36(4). 417–430. 21 indexed citations
11.
Passananti, G. Thomas, et al.. (1981). Antipyrine and warfarin disposition in a patient with idiopathic hypoalbuminemia. Clinical Pharmacology & Therapeutics. 30(6). 810–816. 21 indexed citations
12.
Vesell, Elliot S., Carol A. Shively, & G. Thomas Passananti. (1977). Temporal variations of antipyrine half‐life in man. Clinical Pharmacology & Therapeutics. 22(6). 843–852. 19 indexed citations
13.
Vesell, Elliot S. & G. Thomas Passananti. (1977). Genetic and environmental factors affecting host response to drugs and other chemical compounds in our environment.. Environmental Health Perspectives. 20. 159–182. 8 indexed citations
14.
Passananti, G. Thomas, Carol A. Shively, & Elliot S. Vesell. (1975). ORALLY ADMINISTERED DIMETHYL SULFOXIDE: ITS EFFECTS ON BLOOD CONCENTRATIONS OF SALICYLIC ACID, SULFANILAMIDE, AND WARFARIN*. Annals of the New York Academy of Sciences. 243(1). 311–316. 4 indexed citations
15.
Vesell, Elliot S., et al.. (1973). Studies on the metabolism in man of oxisuran, a differential immunosuppressive drug. Clinical Pharmacology & Therapeutics. 14(6). 1013–1021. 6 indexed citations
16.
Vesell, E.S., et al.. (1972). Effects of Chronic Prazepam Administration on Drug Metabolism in Man and Rat. Pharmacology. 7(3). 197–206. 15 indexed citations
17.
Vesell, Elliot S., John G. Page, & G. Thomas Passananti. (1971). Genetic and environmental factors affecting ethanol metabolism in man. Clinical Pharmacology & Therapeutics. 12(2part1). 192–201. 150 indexed citations
18.
Vesell, Elliot S., G. Thomas Passananti, & Frank E. Greene. (1970). Impairment of Drug Metabolism in Man by Allopurinol and Nortriptyline. New England Journal of Medicine. 283(27). 1484–1488. 114 indexed citations
19.
Leighty, Edith G., et al.. (1967). Effects of Acute Asphyxia and Deep Hypothermia on the State of Binding of Lysosomal Acid Hydrolases in Canine Cardiac Muscle. Circulation Research. 21(1). 59–64. 27 indexed citations
20.
Passananti, G. Thomas, N.B. Guerrant, & Robert Q. Thompson. (1958). Effects of Supplementary Methionine and Choline on Tissue Lipides and on the Vascular Structure of Cholesterol-Fed Growing Rats. Journal of Nutrition. 66(1). 55–74. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L.J. Fischer Breakdown of academic impact, for papers by Frank E. Greene Breakdown of academic impact, for papers by Carol B. Pantuck Breakdown of academic impact, for papers by DS Davies Breakdown of academic impact, for papers by N. Rietbrock Breakdown of academic impact, for papers by W Kalow Breakdown of academic impact, for papers by Eugene J. Pantuck Breakdown of academic impact, for papers by GC Kahn Breakdown of academic impact, for papers by W Klinger Breakdown of academic impact, for papers by D. Kadar
Rankless by CCL
2026